VEF MANAGEMENT III LLC

CIK 00012392463 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001239246

Recent Transactions

50 trades

Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−1,031→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−25,233→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+41,270→ 1,265,504 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+214,820→ 214,820 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+25,233→ 30,600 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−1,009,414→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−41,270→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+227,117→ 275,450 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,031→ 31,631 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,009,414→ 1,224,234 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+15,446→ 47,077 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+48,333→ 48,333 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+617,868→ 1,883,372 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+214,820→ 214,820 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+48,333→ 48,333 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−32,086→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+9,285→ 284,735 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,031→ 31,631 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+139,019→ 423,754 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+617,868→ 1,883,372 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+15,446→ 47,077 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+139,019→ 423,754 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+617,868→ 1,883,372 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−25,233→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−41,270→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−1,031→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+5,367→ 5,367 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−142,607→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−1,009,414→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,009,414→ 1,224,234 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−227,117→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−3,563→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+227,117→ 275,450 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−9,285→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+25,233→ 30,600 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+41,270→ 1,265,504 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+214,820→ 214,820 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+5,367→ 5,367 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−142,607→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−3,563→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−227,117→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−32,086→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−9,285→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−41,270→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−1,009,414→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−142,607→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−25,233→ 0 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+15,446→ 47,077 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+41,270→ 1,265,504 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+9,285→ 284,735 total

Companies

Recent Filings

4
Vitae Pharmaceuticals, Inc
Oct 1, 2014

Address

C/O VENROCK 3340 HILLVIEW AVE.

PALO ALTO, CA, 94304

View on SEC.gov